By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


Key Statistics

Ownership: Public

Web Site: Capricor
Symbol: CAPR


Company News
Capricor (CAPR) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/11/2017 11:30:02 AM
Capricor (CAPR) Second Quarter 2017 Update Webcast And Conference Call Scheduled For Thursday, August 10 8/4/2017 9:20:20 AM
Capricor (CAPR) Announces Results Of FDA Meeting On Intravenous CAP-1002 For Duchenne Muscular Dystrophy 7/27/2017 7:28:13 AM
Capricor (CAPR) Receives Rare Pediatric Disease Designation From FDA For CAP-1002 For Patients With Duchenne Muscular Dystrophy 7/18/2017 8:01:45 AM
Capricor (CAPR) Falls as Johnson & Johnson (JNJ) Bails on Stem Cell Heart Med 7/7/2017 5:50:30 AM
Capricor Announces Upcoming Events In Duchenne Muscular Dystrophy Program 5/31/2017 8:53:42 AM
Capricor Announces Formation Of Duchenne Muscular Dystrophy Advisory Board 5/25/2017 9:31:07 AM
Capricor Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/16/2017 10:57:25 AM
SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results 5/12/2017 6:09:04 AM
Capricor Therapeutics, Inc. Announces Private Placement Of Common Stock 5/8/2017 8:21:15 AM